INTRODUCTIONApplication of Mechanism of ActionIs there another dermatosis besides seborrheic dermatitis that we treat with either steroids or antifungals, or even both in combination? This tells us that with seborrheic…

INTRODUCTION Psoriasis is a chronic and potentially debilitating disease that affects 2% to 3% of the population.1, 2 Approximately 50% of these patients are female, many of childbearing potential. A…

INTRODUCTIONKeratosis pilaris (KP) is a common disorder featuring grouped keratotic follicular papules with varying degrees of perifollicular erythema. Lesions are characteristically located on the extensor surfaces of the upper arms,…

CASE REPORT A 15-year-old Caucasian male presented to our clinic with a 1.5-year history of widespread gray and red patches that began on his trunk and later spread to his…

INTRODUCTIONThe ability to heal wounds is an ever-evolving skill documented throughout human history. Without medical intervention, most traumatic and surgical wounds heal on their own, although it may take a…

Dr. Agustus Ravogli, regarded by many as one of the founders of modern-day dermatology, established The University of Cincinnati Department of Dermatology in 1896. This rich history and long heritage…

DISCLOSURESThe authors have no relevant conflicts of interest to disclose.AUTHOR CORRESPONDENCELauren E. Dubas MDgebauele@ucmail.uc.edu

INTRODUCTION Pattern recognition remains a valuable tool in the accurate diagnosis of dermatologic disease. A comprehensive patient history and physical examination denote cornerstones of medical evaluation, and in our specialty,…

EpidemiologyThough MF is the most common subtype of CTCL, it is still a relatively uncommon malignancy. United States data is obtained from cancer registries that take part in the Surveillance,…

Lambrolizumab for Advanced Melanoma Merck has announced that the FDA has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma. Lambrolizumab is Merck’s investigational…

INTRODUCTIONHyaluronic acid (HA) is a glycosaminoglycan composed of alternating D-glucuronic acid and N-acetyl- D-glucosamine monosaccharide residue. These are cross-linked to form long unbranched chains, which form an anionic biopolymer. The…

INTRODUCTIONPhotodynamic therapy (PDT) has been a relatively late addition to the treatment modalities available to the dermatologist.5 This review will provide a survey of recent preclinical and clinical data that…